Dr. Alireza Eghtedar
Claim this profileColorado Blood Cancer Institute
Studies Acute Myelogenous Leukemia
Studies Leukemia
12 reported clinical trials
25 drugs studied
Area of expertise
1Acute Myelogenous Leukemia
HLA-A positive
HLA-A negative
HLA positive
2Leukemia
HLA-A negative
HLA-A positive
HLA positive
Affiliated Hospitals
Clinical Trials Alireza Eghtedar is currently running
DSP-5336
for Leukemia
This trial is testing a new drug called DSP 5336 to help treat adults with certain types of blood cancer that have come back or didn't respond to previous treatments. The study will first find the best amount to give and then check how safe and helpful it is.
Recruiting1 award Phase 1 & 215 criteria
SENTI-202
for Blood Cancers
This is an open-label study of the safety, biodynamics, and anti-cancer activity of SENTI-202 (an off-the-shelf logic gated CAR NK cell therapy) in patients with CD33 and/or FLT3 expressing blood cancers, including AML and MDS.
Recruiting1 award Phase 14 criteria
More about Alireza Eghtedar
Clinical Trial Related4 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Alireza Eghtedar has experience with
- Orca-T
- Azacitidine
- Dexamethasone
- Elotuzumab
- Pomalidomide
- Standard-of-Care
Breakdown of trials Alireza Eghtedar has run
Acute Myelogenous Leukemia
Leukemia
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alireza Eghtedar specialize in?
Alireza Eghtedar focuses on Acute Myelogenous Leukemia and Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Alireza Eghtedar currently recruiting for clinical trials?
Yes, Alireza Eghtedar is currently recruiting for 4 clinical trials in Denver Colorado. If you're interested in participating, you should apply.
Are there any treatments that Alireza Eghtedar has studied deeply?
Yes, Alireza Eghtedar has studied treatments such as Orca-T, Azacitidine, Dexamethasone.
What is the best way to schedule an appointment with Alireza Eghtedar?
Apply for one of the trials that Alireza Eghtedar is conducting.
What is the office address of Alireza Eghtedar?
The office of Alireza Eghtedar is located at: Colorado Blood Cancer Institute, Denver, Colorado 80218 United States. This is the address for their practice at the Colorado Blood Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.